News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Chiesi Farmaceutici SpA To Launch New Modulite (R) HFA Product In The UK



7/25/2006 6:11:45 PM

Chiesi Farmaceutici S.p.A. announced today the UK launch of Clenil® Modulite® (beclometasone dipropionate[BDP]) a CFC-free pMDI for asthma. Trinity-Chiesi Pharmaceutical, will launch the product. In England, over 7 million prescriptions are written every year for CFC-containing BDP products and Clenil®Modulite® will be the second CFC-free BDP inhaler and the only one that will have a dose-for-dose equivalence to the current CFC products. This innovation will provide a seamless transition for patients to switch to this new product without having to change their usual dose.



comments powered by Disqus
   
Asthma

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES